Your session is about to expire
← Back to Search
allopregnanolone for Alcoholism
Study Summary
This trial will test whether allopregnanolone can help heavy drinkers by reducing stress-induced cravings and anxiety.
- Alcoholism
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You cannot have an addiction to any drugs except for tobacco, alcohol, and marijuana.You cannot participate if you are taking medications for alcoholism, sedatives, or antibiotics/antifungal medications. If you are taking psychotropic medication for a current psychiatric condition, you are also not eligible.You have a serious mental illness such as depression, schizophrenia, or severe anxiety disorder.You are not currently seeking treatment for alcohol use disorder (AUD) as defined by the DSM-5.
- Group 1: allopregnanolone
- Group 2: placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the enrollment for this medical trial open to individuals under 35 years of age?
"The given inclusion criteria indicates that prospective participants must be between the age of 21 and 50."
Am I eligible to enroll in this clinical experiment?
"This study is enrolling 60 individuals between the ages 21 and 50 who have an alcohol use disorder. In addition to this, further requirements for enrolment include being non-treatment seeking with a DSM-5 AUD diagnosis, not having any extra substance abuse issues apart from tobacco, alcohol and marijuana, no medical concerns or abnormal ECG readings as well as women needing to be pregnancy screened before joining in."
Is the enrollment period for this trial open?
"Affirmative. Clinicaltrials.gov reveals that this trial has been accepting recruits since July 1st 2019 and is still actively seeking new patients as of October 20th 2022, with the goal of enrolling 60 people at a single site."
Has the Federal Drug Administration authorized allopregnanolone for use?
"The safety of allopregnanolone is rated a 1 due to it being in Phase 1 trials, meaning there is only minimal information on its efficacy and the risk-benefit ratio."
How many participants is the maximum capacity of this clinical trial?
"Affirmative. As per clinicaltrials.gov, this medical trial is currently recruiting patients and was initially made public on the 1st of July 2019 before being revised lastly on October 20th 2022. The study demands 60 participants from a single site."
Share this study with friends
Copy Link
Messenger